Three Strategies to Reduce Data Friction and Build Leaner Clinical Data Management Operations

Clinical trials have evolved into complex data ecosystems, drawing information from EDC systems, central laboratories, imaging vendors, wearable devices, electronic health records, safety systems, and specialized external vendors. For clinical data managers, this growth has created an opportunity to generate richer evidence faster—but it has also exposed a persistent operational bottleneck: data friction.

"Data friction is the resistance that occurs when clinical data must move across systems, teams, formats, standards, and workflows before it becomes usable," writes Shashidar Reddy Abbidi, senior clinical data manager, in a recent analysis. "It shows up as delayed transfers, manual reconciliation, inconsistent mappings, duplicated review, unresolved queries, unclear ownership, and slow movement from collection to decision-ready data."

As BCG (搜索)搜索该公司 has noted, sponsors' expectations are rising, with demands for greater consistency in speed and quality, better technology, and improved implementations. The traditional CDM workflow—marked by lengthy database build times, heavy reliance on specialized technical programmers, and siloed resources—struggles to keep pace.

Where Data Friction Begins

Data friction originates at the intersection of fragmented technology and fragmented accountability. At the trial level, data may originate in EDC, laboratories, imaging platforms, wearables, EHRs, and other specialized systems, each with different formats, standards, interfaces, and transfer cycles. Before those data can be reviewed together, they often must be mapped, transformed, reconciled, and validated. Every handoff creates an opportunity for latency, inconsistency, or error.

At the organizational level, friction increases when functions work from different tools, assumptions, or definitions of readiness. Data management may focus on completeness and query resolution, while clinical operations prioritizes site follow-up and monitoring. Biostatistics may need analysis-ready data aligned with the statistical analysis plan, but regulatory teams may focus on traceability, explainability, and submission expectations.

"Data friction should be understood as a system-design issue rather than a data management problem alone," Abbidi argues. "The solution requires shared standards, clearer ownership, fit-for-purpose automation, and workflows designed around how data will be used not just how it is collected."

Three Levers to Reduce Data Friction

1. Design automation around bottlenecks, not buzzwords

Automation is most valuable when it targets specific friction points. Examples include automated data ingestion, file checks, reconciliation rules, real-time validation, anomaly detection, and exception-based review. External lab reconciliation can benefit from automated checks for subject identifiers, visit windows, collection dates, units, missing results, and expected versus received records. Imaging data reconciliation can similarly benefit from exception-based tracking of missing scans, assessment dates, and adjudication status.

"Automation should not replace expert review; it should reduce avoidable manual effort so experts can focus on interpretation, risk, and decisions," Abbidi notes.

2. Apply standards early and consistently

CDISC (搜索)搜索该词条 standards support clinical research data consistency and interoperability, but they only reduce friction when sponsors and their teams implement them consistently across study design, collection, vendor specifications, transformations, analysis datasets, and metadata. CDASH thinking can improve collection design, while SDTM and ADaM awareness can inform downstream traceability. FHIR-to-CDISC mapping can help bridge healthcare and research data when EHR-derived sources are in scope.

"Standards should not be treated as a late-stage programming exercise," Abbidi emphasizes. "They should influence protocol data strategy, CRF design, vendor data transfer specifications, edit checks, review plans, external data expectations, and analysis readiness."

3. Redesign processes to reduce handoffs

Data friction increases when work passes through too many unclear handoffs. A cleaner operating model defines ownership, decision rights, escalation paths, expected turnaround times, and evidence requirements. Each external source should have a clear owner, documented transfer expectations, issue triage rules, reconciliation frequency, and escalation path. Clinical operations, data management, programming, and biostatistics should agree on what constitutes a blocking issue versus a documented residual risk.

Building a Leaner CDM Function

Deepa Avinash, head of data management at ClinicalDM by Inventiv Matrix (搜索)搜索该词条, outlines complementary strategies for creating lean and efficient clinical data management operations.

Lower the technical barrier with codeless tools

Historically, building eCRFs and setting up clinical databases required highly specialized programming skills. "Platforms with intuitive design tools that require no coding knowledge offer an actionable way to build a more agile workforce," Avinash writes. Transitioning to a low-code or no-code environment allows organizations to expand their talent pool, onboarding qualified professionals with strong clinical or pharmaceutical backgrounds who may not have formal programming experience. This approach enables data managers to independently execute a study build from start to finish, accelerate study builds by weeks, and meet trial timelines at higher success rates.

Take full advantage of reusable components

Starting every study build from scratch consumes valuable staff time on repetitive tasks. After completing the first few studies, organizations can draw from reusable components—potentially more than 100 case report forms covering demographics, vital signs, and adverse events. "They can import standard forms when a new study comes in, and within a few hours, have a base study ready to show the client in four weeks instead of the standard 12-16 weeks," Avinash explains.

Adopt a modular mindset

Clinical trials are rarely static. Protocols change, amendments occur, and new requirements emerge. A modular system supporting diverse functions—including electronic data capture, randomization, trial supply management, and electronic patient-reported outcomes—enables teams to meet complex protocol requirements without overhauling the underlying system architecture. "With a simpler user interface, everything resides in a single instance, and data flows in real time between modules," Avinash notes.

Measuring What Matters

Organizations cannot improve what they do not measure. Abbidi recommends a practical measurement framework including data latency (time from source data creation to availability for review), query cycle time, external reconciliation turnaround, first-pass quality (proportion of data or files accepted without rework), manual touchpoints, and submission-readiness indicators. These measures should be monitored throughout the study lifecycle so teams can identify friction early, intervene sooner, and prevent small issues from becoming late-stage blockers.

The Strategic Imperative

The most visible impact of data friction is delay—lost time during reconciliation and cleaning can affect interim analyses, database lock, and regulatory submission preparation. But the larger impact is confidence. "Data friction erodes trust when repeated transformations, fragmented validation steps, and inconsistent handoffs create more opportunities for mistakes," Abbidi writes.

The strategic cost is more consequential still. If decision-makers receive usable data too slowly, organizations become more reactive. Adaptive trial decisions, safety signal evaluation, endpoint interpretation, and operational risk mitigation all depend on timely, trusted data.

"The future of clinical data management will be defined less by how well organizations clean data and more by how well they design data flow from the start," Abbidi concludes. "Organizations that address friction through disciplined standards adoption, targeted automation, and thoughtful process design will be more able to generate trusted insights at speed and to deliver clinical trial data that is not only complete, but truly usable."